Bronchiolitis, Viral
17
1
2
8
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 54/100
23.5%
4 terminated out of 17 trials
66.7%
-19.8% vs benchmark
29%
5 trials in Phase 3/4
50%
4 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (17)
Reducing Overuse of Antibiotics With Decision Support
Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV
Effectiveness of Nirsevimab in Children Hospitalised With RSV Bronchiolitis
SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)
Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis
Pediatric Helmet CPAP Pilot Study
Steroid Use in Non-RSV Bronchiolitis
Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis
Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age
Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis
High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis
Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)
Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis
Hypertonic Saline for Acute Bronchiolitis
Home Oxygen Treatment of Childhood Acute Bronchiolitis
The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children